Clinical Trial Update: Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety and tolerability of the combination of Tropifexor and Licogliflozin, as well as each monotherapy, compared with pl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Licogliflozin
• Tropifexor

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non Alcoholic Steatohepatitis (NASH) | Phase 2 | Status: TERMINATED | Results posted: 2023-12-26